Does EVOLOCUMAB Cause Injection site pain? 9,988 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9,988 reports of Injection site pain have been filed in association with EVOLOCUMAB (REPATHA). This represents 6.7% of all adverse event reports for EVOLOCUMAB.
9,988
Reports of Injection site pain with EVOLOCUMAB
6.7%
of all EVOLOCUMAB reports
3
Deaths
154
Hospitalizations
How Dangerous Is Injection site pain From EVOLOCUMAB?
Of the 9,988 reports, 3 (0.0%) resulted in death, 154 (1.5%) required hospitalization, and 18 (0.2%) were considered life-threatening.
Is Injection site pain Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 9,988 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
Device use error (4,002)
What Other Drugs Cause Injection site pain?
ADALIMUMAB (28,679)
DUPILUMAB (27,799)
ETANERCEPT (24,717)
TIRZEPATIDE (10,989)
DULAGLUTIDE (9,474)
GALCANEZUMAB-GNLM (6,622)
HUMIRA (6,005)
GLATIRAMER (5,003)
LEUPROLIDE (4,678)
EXENATIDE (4,577)
Which EVOLOCUMAB Alternatives Have Lower Injection site pain Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE